Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Ligand-specific conformational transitions and intracellular transport are required for atypical chemokine receptor 3-mediated chemokine scavenging.

Montpas N, St-Onge G, Nama N, Rhainds D, Benredjem B, Girard M, Hickson G, Pons V, Heveker N.

J Biol Chem. 2018 Jan 19;293(3):893-905. doi: 10.1074/jbc.M117.814947. Epub 2017 Nov 27.

2.

Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation.

Ziarek JJ, Kleist AB, London N, Raveh B, Montpas N, Bonneterre J, St-Onge G, DiCosmo-Ponticello CJ, Koplinski CA, Roy I, Stephens B, Thelen S, Veldkamp CT, Coffman FD, Cohen MC, Dwinell MB, Thelen M, Peterson FC, Heveker N, Volkman BF.

Sci Signal. 2017 Mar 21;10(471). pii: eaah5756. doi: 10.1126/scisignal.aah5756.

3.

Analysis of Arrestin Recruitment to Chemokine Receptors by Bioluminescence Resonance Energy Transfer.

Bonneterre J, Montpas N, Boularan C, Galés C, Heveker N.

Methods Enzymol. 2016;570:131-53. doi: 10.1016/bs.mie.2015.09.003. Epub 2015 Nov 29.

PMID:
26921945
4.

Development of novel CXC chemokine receptor 7 (CXCR7) ligands: selectivity switch from CXCR4 antagonists with a cyclic pentapeptide scaffold.

Oishi S, Kuroyanagi T, Kubo T, Montpas N, Yoshikawa Y, Misu R, Kobayashi Y, Ohno H, Heveker N, Furuya T, Fujii N.

J Med Chem. 2015 Jul 9;58(13):5218-25. doi: 10.1021/acs.jmedchem.5b00216. Epub 2015 Jun 18.

PMID:
26042340
5.

Mode of binding of the cyclic agonist peptide TC14012 to CXCR7: identification of receptor and compound determinants.

Montpas N, Cabana J, St-Onge G, Gravel S, Morin G, Kuroyanagi T, Lavigne P, Fujii N, Oishi S, Heveker N.

Biochemistry. 2015 Feb 24;54(7):1505-15. doi: 10.1021/bi501526s. Epub 2015 Feb 11.

PMID:
25669416
6.

Characterization of currently marketed heparin products: adverse event relevant bioassays.

Sommers CD, Montpas N, Adam A, Keire DA.

J Pharm Biomed Anal. 2012 Aug-Sep;67-68:28-35. doi: 10.1016/j.jpba.2012.04.017. Epub 2012 Apr 23.

PMID:
22591805
7.

[Anaphylactoid reactions associated with contaminated heparin from China].

Montpas N, Désormeaux A, Keire D, Adam A.

Ann Pharm Fr. 2011 Sep;69(5):258-64. doi: 10.1016/j.pharma.2011.06.007. Epub 2011 Aug 2. Review. French.

PMID:
21924126
8.

Bradykinin forming capacity of oversulfated chondroitin sulfate contaminated heparin in vitro.

Adam A, Montpas N, Keire D, Désormeaux A, Brown NJ, Marceau F, Westenberger B.

Biomaterials. 2010 Aug;31(22):5741-8. doi: 10.1016/j.biomaterials.2010.03.074. Epub 2010 Apr 27.

9.

Altered cardiac bradykinin metabolism in experimental diabetes caused by the variations of angiotensin-converting enzyme and other peptidases.

Adam A, Leclair P, Montpas N, Koumbadinga GA, Bachelard H, Marceau F.

Neuropeptides. 2010 Apr;44(2):69-75. doi: 10.1016/j.npep.2009.09.004.

10.

[Hypersensitivity reaction and Chinese heparin].

Désormeaux A, Montpas N, Adam A.

Ann Pharm Fr. 2009 May;67(3):169-72. doi: 10.1016/j.pharma.2009.03.003. Epub 2009 Apr 5. French.

PMID:
19446665

Supplemental Content

Loading ...
Support Center